The majority of small-molecule drugs that emerge from today’s discovery pipelines are too poorly water-soluble to allow for reproducible absorption after oral intake. This solubility problem dramatically complicates drug development and prevents patients from accessing potentially life-saving therapeutics.
At SeraNovo, we design, develop and GMP-manufacture solubility-enhancing formulations using our proprietary technology platform that harnesses the unique benefits of deep eutectic solvents.
This website uses cookies to track the usage of it.
More info
